Societies
Andrea Necchi: EBMT Reports Outcomes of Salvage High-Dose Chemotherapy
Andrea Necchi / LinkedIn

Andrea Necchi: EBMT Reports Outcomes of Salvage High-Dose Chemotherapy

Andrea Necchi, Head of Genitourinary Medical Oncology at Ospedale San Raffaele, shared on LinkedIn:

“Contemporary outcomes of salvage high-dose chemotherapy in advanced germ cell tumors:

An analysis of the cellular therapy and immunobiology working party of the EBMT.”

Title: Contemporary outcomes of salvage high-dose chemotherapy in advanced germ cell tumors: an analysis of the cellular therapy and immunobiology working party of the EBMT registry

Authors: V. Tateo, M. Longoni, S. Secondino, C. Castilla Llorente, E. Nicholson, F. Lanza, U. De Giorgi, A. Burchert, M. Stelljes, M. Bandini, M. Badoglio, G. Rosti, J. Kuball, F. Malard, A. Ruggeri, P. Pedrazzoli, A. Necchi

Read the full article.

Other articles from Andrea Necchi on OncoDaily.

A. Burchert A. Necchi A. Ruggeri Andrea Necchi C. Castilla Llorente cancer E. Nicholson EBMT F. Lanza F. Malard G. Rosti Germ Cell Tumors J. Kuball M. Badoglio M. Bandini M. Longoni M. Stelljes OncoDaily Oncology P. Pedrazzoli S. Secondino U. De Giorgi V. Tateo